68Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma.

IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Molecular Imaging and Radionuclide Therapy Pub Date : 2024-02-22 DOI:10.4274/mirt.galenos.2023.47855
Kübra Şahin, Ali Kibar, Cansu Güneren, Muhammet Sait Sağer, Kerim Sönmezoğlu
{"title":"<sup>68</sup>Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma.","authors":"Kübra Şahin, Ali Kibar, Cansu Güneren, Muhammet Sait Sağer, Kerim Sönmezoğlu","doi":"10.4274/mirt.galenos.2023.47855","DOIUrl":null,"url":null,"abstract":"<p><p>We present the case of a 58-year-old man with advanced medullary thyroid carcinoma who had a treatment history with different types of modalities. In the follow-up, the patient had rising calcitonin and CEA levels. Metastatic lymph nodes, liver, and bone metastases with varying degrees of uptake were detected on <sup>18</sup>F-fluorodeoxyglucose (FDG) and <sup>68</sup>Ga-DOTATATE positron emission tomography/computed tomography (PET/CT). <sup>68</sup>Ga prostate-specific membrane antigen (PSMA) PET/CT was performed to explore whether the patient might have a chance for PSMA-targeted radionuclide therapy, and increased PSMA expression was noted in most of the metastatic lesions, even some of which have higher PSMA uptake than <sup>18</sup>F-FDG and <sup>68</sup>Ga-DOTATATE.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10899746/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Radionuclide Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/mirt.galenos.2023.47855","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

We present the case of a 58-year-old man with advanced medullary thyroid carcinoma who had a treatment history with different types of modalities. In the follow-up, the patient had rising calcitonin and CEA levels. Metastatic lymph nodes, liver, and bone metastases with varying degrees of uptake were detected on 18F-fluorodeoxyglucose (FDG) and 68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT). 68Ga prostate-specific membrane antigen (PSMA) PET/CT was performed to explore whether the patient might have a chance for PSMA-targeted radionuclide therapy, and increased PSMA expression was noted in most of the metastatic lesions, even some of which have higher PSMA uptake than 18F-FDG and 68Ga-DOTATATE.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
转移性甲状腺髓样癌的 68Ga 前列腺特异性膜抗原摄取量
本病例是一名 58 岁的晚期甲状腺髓样癌患者,曾接受过不同类型的治疗。随访期间,患者的降钙素原和癌胚抗原水平不断升高。18F-氟脱氧葡萄糖(FDG)和68Ga-DOTATATE正电子发射断层扫描/计算机断层扫描(PET/CT)发现了不同程度摄取的转移性淋巴结、肝脏和骨转移灶。68Ga 前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)是为了探索患者是否有机会接受 PSMA 靶向放射性核素治疗,结果发现大多数转移病灶中 PSMA 表达增加,甚至其中一些病灶的 PSMA 摄取量高于 18F-FDG 和 68Ga-DOTATATE。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Molecular Imaging and Radionuclide Therapy
Molecular Imaging and Radionuclide Therapy RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.
期刊最新文献
Prognostic Importance of 18F-FDG Positron Emission Tomography in Uterine Cervical Cancer Deep-learning-based Attenuation Correction for 68Ga-DOTATATE Whole-body PET Imaging: A Dual-center Clinical Study Diagnosis of Atypical Medullary Metastasis in Melanoma Using 18F-FDG PET/CT The Utility of 18F-FDG PET/CT in Detecting Multiple Metastases in Papillary Renal Cell Carcinoma A Rare Malignancy; Primary Peritoneal Serous Carcinoma in Men with 18F-FDG PET/CT and Histopathology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1